Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Leprosy patients with deformities at post‐elimination stage: The Bangladesh experience

Mowla MR, Angkur DM, Hasan Z, et al. Wiley. Skin Health and Disease. 2020;
Download PDF
Publication

Hand Disability Grading in Leprosy: Associated Risk Factors

Wardhani RK, Wahyuni LK, Harini M, et al. Indian journal of leprosy. 2020;
Download PDF
Publication

Grade 2 Disability in Leprosy and its Predictors: A 10 year Retrospective Study from Kerala, India

Sabeena J, Bindu RS. Indian journal of leprosy. 2020;
Download PDF
Publication

Epidemiological trends of leprosy in Goiás, Brasil.

da Silva C, Sampaio L, de Souza J, et al. Ciencia & saude coletiva. 2020; 25 (10) : 3723-3730.
Download PDF
Publication

[Prevention of physical disabilities due to leprosy in Brazil: a historic analysis].

Rosendo dos Santos A, Ignotti E. Ciencia & saude coletiva. 2020; 25 (10) : 3731-3744.
Download PDF
Publication

Contexto clínico-epidemiológico dos casos de hanseníase notificados em Governador Valadares, Minas Gerais - Brasil, entre 2015 e 2019

Cardoso DM, Gomides TAR. Saúde (Santa Maria). 2020; 46 (2) : e44459.
Download PDF
Publication

Hanseníase: correlação entre o número de lesões hansênicas, nervos afetados e o diagnóstico precoce no estado de Minas Gerais

Pêgo AF, Eleutério D, Procópio JPM, et al. Revista Eletronica Acervo Saude. Revista Eletrônica Acervo Saúde. 2020; 12 (9) : e2188.
Download PDF
Publication

Leprosy in Brazil in the 21st century: analysis of epidemiological and operational indicators using inflection point regression

Souza CDFD, Paiva JPSD, Leal TC, et al. Elsevier BV. Anais Brasileiros de Dermatologia. 2020;
Download PDF
Publication

Depression and mental wellbeing in people affected by leprosy in southern Nepal

van Dorst MMAR, van Netten WJ, Waltz MM, et al. Informa UK Limited. Global Health Action. 2020; 13 (1) : 1815275.
Download PDF
Publication

Evaluation of ocular involvement in patients with Hansen's disease.

Pavezzi P, Prado R, Filho P, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008585.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 40
  • Next page ››
Subscribe to Disability

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD